Stock screener

TENX

Conviction 73HealthcareScan · Mon, Aug 10, 2026
TENX$1.38-89.77%
ResistanceSupportVol 14
63 bars
Vol MA14 5.09M
May 11May 28Jun 16Jul 6Jul 23Aug 10
TENAX THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.tenaxthera.com
Price1.38
Change-89.77%
Gap-86.64%
Rel volume32.33×
Avg volume3.87M
Avg $ vol24.38M
SMA 2014.11
SMA 5013.51
SMA 20012.39
Price vs 50-89.82%
Price vs 200-88.90%
MA stackmixed
50/200 cross
Supertrenddown · 8.40
RSI (14)17
MACD hist-1.07
MACD cross
Stoch %K / %D0 / 8
ADX (14)21
+DI / −DI11 / 54
RSI divergence
MACD divergenceBearish
ATR %+142.80%
ADR %9.27%
52w high18.32
52w low1.38
From 52w high-92.49%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width86.69%
%B-0.54
Donchian pos0.43%
Donchian high16.50
Donchian low1.31
AVWAP (52w high)6.93
vs AVWAP high-80.15%
AVWAP (52w low)1.49
vs AVWAP low-7.92%
OBV trendDown
Chaikin MF (20)-0.50
Today vs 20d32.33×
Avg vol (14d)5.09M
Avg vol (20d)3.87M
Avg $ vol (20d)24.38M
Market cap51.46M
RS 3m (vs SPY)+9.67%
RS 6m (vs SPY)-5.38%
RS line new highNo
Trend template4/8
Technical rank0.3
1 week-90.40%
1 month-92.17%
3 months-88.21%
6 months-89.20%
1 year-77.01%
YTD-87.56%
P/E-0.98
P/B0.45
P/S
P/FCF-1.44
EPS-1.34
Div yield
ROE-46.31%
ROA-43.23%
Debt/Eq
Current15.07
EV/EBITDA1.18
Gross margin
Net margin
Rev growth
EPS growth-198.82%
Price target32.43
Target upside2258.55%
Analyst ratingBuy
Institutional64.60%
Ent. value-66.54M
Revenue0
Net income-17.8M
Gross profit0
Free cash flow-35.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out26.53M
Employees16
ListedWed, Feb 1, 1995
Free float5.59M
Float %89.6%
Short interest2.05M
Days to cover1.4d
Short volume63.5%
Squeeze score77 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.35 vs −$0.38
Last surprise+7.9% beat
Setup gradeB
Conviction73 / 100
Pattern quality
Tech rank0.3 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance17.95
Support13.49
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TENX

All disclosures →
No recent disclosed trades by Congress in TENX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TENX · 2 buys

InsiderSideShares
STAAB THOMAS R II
Chief Financial Officer · Stock Option (right to buy) · 2026-05-11
Grant450K
STAAB THOMAS R II
Chief Financial Officer · Common Stock · 2026-05-11
Grant10K

SEC filings

EDGAR filings in TENX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.